Amrize (NYSE:AMRZ) CFO Baris Oran Purchases 3,000 Shares of Stock

Amrize Ltd (NYSE:AMRZ) CFO Baris Oran bought 3,000 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The shares were acquired at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the transaction, the chief financial officer directly owned 3,000 shares in the company, valued at $142,140. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Amrize Price Performance

Shares of NYSE AMRZ opened at $46.75 on Friday. The company has a market cap of $25.85 billion, a PE ratio of 21.54, a P/E/G ratio of 0.99 and a beta of 0.11. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The business has a 50-day simple moving average of $51.35 and a two-hundred day simple moving average of $54.52. Amrize Ltd has a fifty-two week low of $46.03 and a fifty-two week high of $65.94.

Amrize (NYSE:AMRZ) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.17%. The company had revenue of $3.50 billion for the quarter. As a group, equities analysts expect that Amrize Ltd will post 2.72 EPS for the current fiscal year.

Amrize Dividend Announcement

The company also recently declared a dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize’s payout ratio is currently 20.28%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on AMRZ. Wells Fargo & Company dropped their target price on Amrize from $65.00 to $58.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 8th. Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research note on Monday, June 22nd. Citigroup cut their price objective on shares of Amrize from $66.00 to $58.00 and set a “buy” rating on the stock in a research note on Tuesday. Morgan Stanley set a $63.00 target price on shares of Amrize and gave the stock an “overweight” rating in a report on Monday, June 22nd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a research report on Friday, June 26th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $60.57.

Institutional Investors Weigh In On Amrize

Several hedge funds have recently bought and sold shares of the stock. Great Lakes Advisors LLC purchased a new position in shares of Amrize during the 2nd quarter valued at approximately $16,975,000. HF Advisory Group LLC boosted its holdings in Amrize by 323.3% during the second quarter. HF Advisory Group LLC now owns 21,325 shares of the company’s stock worth $1,137,000 after buying an additional 16,287 shares in the last quarter. Norman Fields Gottscho Capital Management LLC grew its position in Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after buying an additional 475 shares during the period. DMKC Advisory Services LLC grew its position in Amrize by 11.9% during the second quarter. DMKC Advisory Services LLC now owns 67,832 shares of the company’s stock valued at $3,615,000 after buying an additional 7,223 shares during the period. Finally, Grove Bank & Trust increased its holdings in Amrize by 5.6% in the second quarter. Grove Bank & Trust now owns 17,124 shares of the company’s stock valued at $913,000 after buying an additional 906 shares in the last quarter.

Amrize News Roundup

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Stephens maintained a Buy rating on Amrize, reinforcing a favorable analyst view of the building-materials company. Stephens maintains Buy rating on Amrize
• Positive Sentiment: Several Amrize insiders purchased shares on August 11, signaling that company executives may view the recent decline as an attractive entry point. CFO Baris Oran bought 3,000 shares for approximately $142,140, while CTO Roald Brouwer purchased 1,500 shares for about $69,540.
• Positive Sentiment: Additional insider purchases included 5,260 shares by Stephen S. Clark, valued at approximately $248,851; 3,568 shares by Mario Gross, valued at about $166,269; and 1,500 shares by Jaime Hill, valued at roughly $70,680. Collectively, the transactions represent more than $597,000 of insider buying and increased the respective executives’ holdings. Amrize insider purchase filing

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.